Vanguard Capital Management Establishes 5.65% Stake in Journey Medical Corp (DERM)

Vanguard Capital Management LLC has filed a Schedule 13G with the SEC, reporting a new ownership stake in Journey Medical Corp (DERM). As of the event date on March 31, 2026, Vanguard beneficially owns 1,206,395 shares of Common Stock, representing 5.65% of the company's total shares outstanding. This filing marks an increase from a previous position of zero, establishing Vanguard as a significant institutional holder. The reported shares include holdings across various Vanguard affiliates, including Vanguard Global Advisers, LLC and Vanguard Fiduciary Trust Company. According to the filing, Vanguard holds sole dispositive power over all 1,206,395 shares, while possessing sole voting power over 124,315 shares. The acquisition was made in the ordinary course of business, with Vanguard certifying that the shares were not acquired for the purpose of changing or influencing the control of the issuer. The filing was officially signed by Ashley Grim, Head of Global Fund Administration, on April 30, 2026.